000			01771cam a22003017a 4500
001			13313664
003			OSt
005			20251107150446.0
008			030515s2003 sz a b i000 0 eng d
010			_a 2003362254
020			_a9241545992
035			_a(OCoLC)ocm52253251
040			_aPIT _cPIT _dVAM _dDLC
042			_alccopycat
050	0	0	_aRA644.5 _b.A34 2003
082	0	0	_aW85 A41w 2003. _222
100			_aEdited by Sabaté, Eduardo _919508
245	0	0	_aAdherence to Long-term Therapies : _bevidence for action
260			_aGeneva; _bW H O, _c2003.
300			_axv, 198 p. : _bcol. ill. ; _c26 cm.
504			_aIncludes bibliographical references.
505	0		_aCh. I. Defining adherence -- Ch. II. The magnitude of the problem of poor adherence -- Ch. III. How does poor adherence affect policy makers and health managers? -- Ch. IV. Lessons learned -- Ch. V. Towards the solution -- Ch. VI. How can improved adherence be translated into health and economics benefits? -- Ch. VII. Asthma -- Ch. VIII. Cancer (palliative care) -- Ch. IX. Depression -- Ch. X. Diabetes -- Ch. XI. Epilepsy -- Ch. XII. HIV/AIDS -- Ch. XIII. Hypertension -- Ch. XIV. Tobacco smoking cessation -- Ch. XV. Tuberculosis -- Annex I. Behavioural mechanisms explaining adherence -- Annex II. Statements by stakeholders -- Annex III. Table of reported factors by condition and dimension -- Annex IV. Table of reported interventions by condition and dimension -- Annex V. Global adherence interdisciplinary network (GAIN).
650		0	_aChronic diseases _xTreatment. _916516
650		0	_aTherapies _916517
906			_a7 _bcbc _ccopycat _d3 _encip _f20 _gy-gencatlg
942			_2ddc _cO_SHELF
999			_c8103 _d8103